1230487-11-2 Usage
Uses
Used in Pharmaceutical Research and Development:
Pneumocandin B0, 1-[(4R,5R)-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-5-[(4-methylphenyl)thio]-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]is used as a reference standard for the study of antifungal agents and their mechanisms of action. It aids in understanding the effectiveness of echinocandins against fungal infections and contributes to the development of new antifungal drugs.
Used in Antifungal Treatments:
In the medical industry, Pneumocandin B0, 1-[(4R,5R)-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-5-[(4-methylphenyl)thio]-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]is used as a potential treatment for fungal infections. It is particularly valuable for addressing infections caused by resistant strains due to its potent inhibitory activity against β-(1,3)-D-glucan synthesis, which is essential for the integrity of the fungal cell wall.
Used in Drug Resistance Studies:
Pneumocandin B0, 1-[(4R,5R)-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-5-[(4-methylphenyl)thio]-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]is utilized in research to investigate drug resistance in fungi. Understanding the mechanisms by which fungi develop resistance to antifungal agents like Pneumocandin B0 can inform the development of more effective treatments and strategies to combat resistant strains.
Check Digit Verification of cas no
The CAS Registry Mumber 1230487-11-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,0,4,8 and 7 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1230487-11:
(9*1)+(8*2)+(7*3)+(6*0)+(5*4)+(4*8)+(3*7)+(2*1)+(1*1)=122
122 % 10 = 2
So 1230487-11-2 is a valid CAS Registry Number.
1230487-11-2Relevant academic research and scientific papers
Process for preparation of Caspofungin acetate
-
Page/Page column 5, (2010/07/08)
A process for making caspofungin acetate comprising the steps of: A. selectively dehydrating pneumocandin Bo to obtain a nitrile;B. reducing the nitrile to primary amine;C. reacting the primary amine with an arylthiol in a suitable solvent to obtain a thi
